Nebert DW, Zhang G, Vesell ES: From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008, 40: 187–224. 10.1080/03602530801952864
Article
PubMed Central
CAS
PubMed
Google Scholar
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI: The human microbiome project. Nature 2007, 449: 804–810. 10.1038/nature06244
Article
PubMed Central
CAS
PubMed
Google Scholar
Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, et al.: The NIH Human Microbiome Project. Genome Res 2009, 19: 2317–2323. 10.1101/gr.096651.109
Article
PubMed Central
PubMed
Google Scholar
Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK: Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009, 106: 14728–14733. 10.1073/pnas.0904489106
Article
PubMed Central
CAS
PubMed
Google Scholar
Wilson ID, Nicholson JK: The role of gut microbiota in drug response. Curr Pharm Des 2009, 15: 1519–1523. 10.2174/138161209788168173
Article
CAS
PubMed
Google Scholar
Wilson ID: Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci USA 2009, 106: 14187–14188.
Article
PubMed Central
CAS
PubMed
Google Scholar
Rizkallah M, Saad R, Aziz R: The Human Microbiome Project, personalized medicine and the birth of pharmacomicrobiomics. Cur Pharmacog Personalized Med (Formerly Current Pharmacog) 2010, 8: 182–193.
Article
CAS
Google Scholar
Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K: Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000, 52: 1563–1568. 10.1211/0022357001777621
Article
CAS
PubMed
Google Scholar
Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J: Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 1989, 30: 971–977. 10.1136/gut.30.7.971
Article
PubMed Central
CAS
PubMed
Google Scholar
Gonthier MP, Verny MA, Besson C, Remesy C, Scalbert A: Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 2003, 133: 1853–1859.
CAS
PubMed
Google Scholar
Lhoste EF, Ouriet V, Bruel S, Flinois JP, Brezillon C, Magdalou J, Cheze C, Nugon-Baudon L: The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 2003, 41: 695–702. 10.1016/S0278-6915(03)00010-3
Article
CAS
PubMed
Google Scholar
Kitamura S, Sugihara K, Kuwasako M, Tatsumi K: The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide. J Pharm Pharmacol 1997, 49: 253–256. 10.1111/j.2042-7158.1997.tb06790.x
Article
CAS
PubMed
Google Scholar